Syngen Biotech Co.,Ltd.

NT$80.30As of Sun 8 Nov 2026, 12:00 UTC
TPEx:8279Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (0.85%)
Div yield 6.23%
ROE 8.64%
Biotechnology
Beta (5Y) 0.11
PE TTM 10.65
TSR TTM (37.20%)
Mkt cap NT$2.176B
ROIC 8.67%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$102
26.82%
(51.26%)
Hold 5|4|11|11|12
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.88
0.89
0.94
1.00
12.96%
14.35%
15.02%
15.64%
RevenueNT$M
276.9
275.7
283.9
276.5
(0.37%)
1.04%
0.77%
(2.52%)
Peers (US$65.73M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.623
0.177
0.180
EBIT/Intx
3.150
0.391
0.418
Own earn%
44.43
(65.83)
(50.64)
Sh yield%
17.83
27.44
33.71
Owners
Insiders/Inst%
2.10
59.43
Short interest%
0.88
SBC / revenue%
1.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
6–11
$1 testx
—
Incr. ROIC%
3